APA

Lok B. H., Gardner E. E., Schneeberger V. E., Ni A., Desmeules P., Rekhtman N., de Stanchina E., Teicher B. A., Riaz N., Powell S. N., Poirier J. T. & Rudin C. M. (20180206). PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Lok Benjamin H, Gardner Eric E, Schneeberger Valentina E, Ni Andy, Desmeules Patrice, Rekhtman Natasha, de Stanchina Elisa, Teicher Beverly A, Riaz Nadeem, Powell Simon N, Poirier John T and Rudin Charles M. 20180206. PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Lok B. H., Gardner E. E., Schneeberger V. E., Ni A., Desmeules P., Rekhtman N., de Stanchina E., Teicher B. A., Riaz N., Powell S. N., Poirier J. T. and Rudin C. M. (20180206). PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Lok Benjamin H, Gardner Eric E, Schneeberger Valentina E, Ni Andy, Desmeules Patrice, Rekhtman Natasha, de Stanchina Elisa, Teicher Beverly A, Riaz Nadeem, Powell Simon N, Poirier John T and Rudin Charles M. PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20180206.